Animalcare Group plc (AIM:ANCR)

London flag London · Delayed Price · Currency is GBP · Price in GBX
333.50
0.00 (0.00%)
Jul 21, 2026, 5:15 PM GMT
Market Cap230.27M +14.7%
Revenue (ttm)89.11M +20.0%
Net Income5.08M -72.5%
EPS0.07 -75.6%
Shares Out 69.05M
PE Ratio45.69
Forward PE24.17
Dividend0.05 (1.56%)
Ex-Dividend DateOct 16, 2025
Volume113,879
Open332.00
Previous Close333.50
Day's Range332.00 - 333.50
52-Week Range216.00 - 340.00
Beta0.67
Analystsn/a
Price Targetn/a
Earnings DateSep 24, 2026

About Animalcare Group

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally. It operates through Animalcare Europe and Randlab segments. The company offers Orozyme, an enzymatic toothpaste for dental care in cats and dogs; Danilon, an oral treatment for pain in horses; Dinalgen, an injectable treatment for pain in cattle, pigs, and horses; Aqupharm, a dehydration treatment for cats, dogs, cattle, goats, horse... [Read more]

Sector Healthcare
CEO Jennifer Ann Winter
Employees 220
Stock Exchange London Stock Exchange AIM
Ticker Symbol ANCR
Full Company Profile

Financial Performance

In 2025, Animalcare Group's revenue was 89.11 million, an increase of 20.04% compared to the previous year's 74.23 million. Earnings were 5.08 million, a decrease of -72.54%.

Financial Statements

News

Animalcare Group Annual report: H2 2025

Animalcare Group has published its H2 2025 annual report on May 6, 2026.

2 months ago - Filings

Animalcare Group Annual report: H2 2025

Animalcare Group has published its H2 2025 annual report on May 6, 2026.

2 months ago - Filings

AIM Market Roundup: Animalcare, Mothercare, Strip Tinning

Animalcare, Mothercare, Strip Tinning are today's top risers, while Quantum Blockchain, Wellnex Life take the biggest fall on London's AIM

3 months ago - The Armchair Trader

Animalcare Group Transcript: CMD 2026

Ambitious plans target GBP 150 million revenue by 2030, leveraging organic growth, M&A, and innovation. Margin and EBITDA improvements are driven by product mix, supply chain optimization, and commercial excellence, while a robust R&D pipeline and strategic acquisitions support expansion in key markets.

4 months ago - Transcripts

Animalcare Group Slides: FY 2026

Animalcare Group has posted slides in relation to its FY 2026 quarterly earnings report, which was published on March 4, 2026.

4 months ago - Filings

Animalcare Group Earnings release: Trading update

Animalcare Group released its earnings on January 22, 2026, summarizing the period's financial results.

6 months ago - Filings

Half Year 2025 Animalcare Group plc Investor Presentation Transcript

Half Year 2025 Animalcare Group plc Investor Presentation Transcript

9 months ago - GuruFocus

Animalcare Group Earnings Call Transcript: H1 2025

Revenue grew 18.3% year-over-year, driven by Randlab's strong integration and organic performance. Margins and cash flow improved, with robust investment in R&D and a healthy M&A pipeline. Regulatory and FX headwinds were managed, and the outlook remains positive.

10 months ago - Transcripts

Animalcare Group Quarterly report: H1 2025

Animalcare Group has published its H1 2025 quarterly earnings report on October 6, 2025.

10 months ago - Filings

Animalcare Group Slides: H1 2025

Animalcare Group has posted slides in relation to its H1 2025 quarterly earnings report, which was published on October 6, 2025.

10 months ago - Filings

Animalcare sees revenue growth and improved cash position

Animalcare has a transformational year as disposal of Identicare and STEM sees cash position swell to GBP32.9m

1 year ago - The Armchair Trader